MARKET

KTOV

KTOV

Kitov Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3599
+0.0349
+10.74%
After Hours: 0.3505 -0.0094 -2.61% 19:58 04/09 EDT
OPEN
0.3310
PREV CLOSE
0.3250
HIGH
0.3700
LOW
0.3105
VOLUME
5.13M
TURNOVER
--
52 WEEK HIGH
1.630
52 WEEK LOW
0.2200
MARKET CAP
908.49K
P/E (TTM)
-0.0596
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average KTOV stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.

EPS

KTOV News

More
  • Kitov Closes $6.0 Million Public Offering
  • GlobeNewswire · 03/17 13:00
  • U.S. launch of Kitov Pharma's Consensi set for May
  • Seeking Alpha - Article · 03/12 15:14
  • Kitov Pharma Provides Update on Planned U.S. Launch of Consensi and Provides Three-Year Revenue Forecast
  • GlobeNewswire · 03/12 13:15
  • Kitov Announces Pricing of $6.0 Million Public Offering
  • GlobeNewswire · 03/12 13:00

Industry

Biotechnology & Medical Research
+1.63%
Pharmaceuticals & Medical Research
+0.82%

Hot Stocks

Symbol
Price
%Change

About KTOV

Kitov Pharma Ltd, formerly Kitov Pharmaceuticals Holdings Ltd, is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
More

Webull offers kinds of Kitov Pharma Ltd stock information, including NASDAQ:KTOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KTOV stock news, and many more online research tools to help you make informed decisions.